NCT07203911Recruiting
Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 13 May 2026
Brief summary (registry, in English)
The goal of this clinical trial is to improve the surgical treatment of patients with oral cancer. We will explore whether the use of surgeon performed ultrasound during these surgeries result in better tumor removal. We hypothesize that using intraoperative ultrasound to assist the resection results in more frequent clear surgical margins in oral cancer surgeries compared to standard methods. This improvement is associated with a reduced need for post-operative adjuvant therapies such as radiotherapy and reoperation, lower mortality rates, lower cancer recurrence, and enhanced quality of life for patients undergoing surgery for oral cancer. Participants will be randomized to either the control or intervention group: * Control group will receive standard treatment for oral cancer. * Intervention group will in addition to the standard treatment have surgery performed using ultrasound to guide the resection and evaluate resection margins intraoperatively. Outcomes: * Number of free surgical margins between control and intervention group. * Intraoperative surgeon assessed surgical margins compared to final histology report. * Dysphagia and quality of life questionnaires. * Recurrence rates. * Mortality rates. All participant will be followed-up at 3 months and 12 months with: * MDADI dysphagia questionnaire * EORTC head and neck cancer quality of life questionnaire * Follow-up on recurrrence and mortality.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 24 Sept 2025
- Start date
- 15 Sept 2025
- Primary completion date
- 15 Sept 2027
- Lead sponsor
- Tobias Todsen
- Diseases
- Head and neck cancer
- NCT number
- NCT07203911
What you commit to
- Study type: Interventional
- Planned participants: 150
- From 15 Sept 2025 to the primary completion date, 15 Sept 2027
- 7 sites in 5 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior radiotherapy treatment of oral cavity cancer.
Other illness
- Oral cancer with suspected bone involvement.
Age
- Age \< 18 years.
Other
- Unable to understand verbal or written information.
- Tumor not visible on ultrasound.
Who the study is looking for
- Patients scheduled for surgical treatment of biopsy-proven T1-T3 oral squamous cell carcinoma.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Otorhinolaryngology Head and Neck Surgery Coordinator of this site? Confirm its status | Aarhus | Denmark | Recruiting |
| Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen | Denmark | Recruiting |
| Istituto Nazionale Tumori of Milan Coordinator of this site? Confirm its status | Milan | Italy | Not yet recruiting |
| Karolinska Institute Coordinator of this site? Confirm its status | Stockholm | Sweden | Recruiting |
| Emory University Hospital Coordinator of this site? Confirm its status | Atlanta | United States | Not yet recruiting |
| Stanford Otolaryngology - Head & Neck Surgery Department Coordinator of this site? Confirm its status | Stanford | United States | Not yet recruiting |
| Groote Schuur Coordinator of this site? Confirm its status | Cape Town | South Africa | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.